 - 5 patients will be treated with 4 weeks of imatinib mesylate 400mg per day the lowest typical starting dose to be started concurrently with ranibizumab Lucentis 0.5mg intravitreal injection. The patients would be injected at monthly intervals for the first 3 months followed by treatment on an as needed basis. 